• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION UPHOLD VAGINAL SUPPORT SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION UPHOLD VAGINAL SUPPORT SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN Back to Search Results
Model Number M0068317080
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Incontinence (1928); Pain (1994); Abnormal Vaginal Discharge (2123); Constipation (3274); Dyspareunia (4505)
Event Date 04/08/2021
Event Type  Injury  
Manufacturer Narrative
(b)(6).The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.The upn provided was chosen as a representative upn to capture the implanted device.The complainant indicated that the device is not available for return; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an uphold was implanted on (b)(6) 2012.The patient experienced complications and nonsurgical treatment.Patient symptoms include: back pain; vaginal pain; pelvic pain; pain inter; inab inter; off vag dis; diff bowel; rec incont nonsurgical treatments: on (b)(6) 2021 the patient commenced other medication (please specify): ibilex 250mg for the treatment of: long term interstitial cystitis.Treatment duration: 6 months.On (b)(6) 2021 the patient commenced topical treatment (including oestrogen cream): ovestin cream for the treatment of: soften the vaginal wall.Treatment duration: continuous.On (b)(6) 2021 the patient commenced other (please specify) for the treatment of: soften vaginal walls.Treatment duration: continueous.
 
Manufacturer Narrative
Additional information to blocks a1: patient's initials, b5, d4: lot number, e1: physician's name and healthcare facility, g4: premarket 510k, and h4: manufacture date.Block a1: (b)(6).Block e1: this event was reported by the patient's legal representative.The implant surgeon is: (b)(6).Block h6: patient code e2330 captures the reportable event of pain (back pain, vaginal pain, pelvic pain).Conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an uphold vaginal support system was implanted during an anterior vaginal repair with apical fixation using uphold mesh, posterior vaginal repair, perineoraphy, and cystoscopy procedure performed on (b)(6), 2012.The postoperative findings of the patient were grade 2 cystocele, vault prolapse grade 1, and rectocele grade 1.There was significant scar tissue between the anterior vaginal wall and the bladder.Additionally, the cystoscopy results showed no mesh in the bladder.The bladder was normal in appearance, and there was no evidence of detrusor activity.Post-procedure, the patient experienced complications and nonsurgical treatment(s).Patient symptoms include: back pain, vaginal pain, pelvic pain, painful intercourse, inability to have sexual intercourse, offensive vaginal discharge, difficulty in bowel movement, and recurrent incontinence.Nonsurgical treatments: on (b)(6) 2021, the patient commenced medications such as ibilex 250mg for the treatment of long-term interstitial cystitis for the duration of 6 months.The patient was also treated with topical treatment, ovestin cream (including oestrogen cream) to soften the vaginal wall continuously.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UPHOLD VAGINAL SUPPORT SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
FREUDENBERG MEDICAL MIS INC
2301 centennial boulevard
jeffersonville IN 47130
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key12930683
MDR Text Key286869617
Report Number3005099803-2021-06892
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K081048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2015
Device Model NumberM0068317080
Device Catalogue Number831-708
Device Lot NumberML00000705
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 11/10/2021
Initial Date FDA Received12/04/2021
Supplement Dates Manufacturer Received08/11/2022
Supplement Dates FDA Received09/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/26/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexFemale
Patient Weight74 KG
-
-